Back to Archived Journals » Core Evidence » Volume 2 » Issue 2
Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Core Evidence
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 2, 2007
Insulin glargine in the management of diabetes mellitus: an evidence-based assessment of its clinical efficacy and economic value
Rhian Clissold, Steve Clissold
Core Evidence 2007, 2:0-0
Published Date: 15 June 2007
Panitumumab: the evidence of its therapeutic potential in metastatic colorectal cancer care
Erika Martinelli, Floriana Morgillo, Teresa Troiani, Giampaolo Tortora, et al.
Core Evidence 2007, 2:0-0
Published Date: 15 June 2007
Rituximab maintenance in relapsed or refractory follicular non-Hodgkin’s lymphoma: the evidence of its therapeutic value
Kirit M. Ardeshna
Core Evidence 2007, 2:0-0
Published Date: 15 June 2007
Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis
Louise Profit, Paul Chrisp
Core Evidence 2007, 2:0-0
Published Date: 15 June 2007
Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas
David B. Smith, John P. Neoptolemos
Core Evidence 2007, 2:0-0
Published Date: 15 June 2007